08 August 2021 : Clinical Research
Magnetic Resonance Imaging (MRI)-Targeted Biopsy in Patients with Prostate-Specific Antigen (PSA) Levels <20 ng/mL: A Single-Center Study in Northeastern China
Zhihong Dai
1ABCDEF, Yangyang Liu 1ABCDE, Zhao Huangfu1DF, Liang Wang 1CDEG, Zhiyu Liu 1CDEG*
DOI: 10.12659/MSM.930234
Med Sci Monit 2021; 27:e930234
Table 1 Basic characteristics of the study population.
| Biopsy | |
|---|---|
| Patients (n) | 218 |
| Age at biopsy, years (median, IQR) | 63 (9) |
| PSA, ng/mL(median, IQR) | 8.70 (8) |
| Prostate volume, mL (median, IQR) | 50.02 (25) |
| Abnormal DRE, n (%) | 35 (16.06%) |
| Maximum PI-RADS v2 score, n | |
| 3 | 112 |
| 4 | 78 |
| 5 | 28 |
| PSAD – prostate specific antigen density; DRE – digital rectum examination; PSA – prostate-specific antigen; SD – standard deviation; PI-RADS v2 – Prostate Imaging Recording and Data System version 2.0; IQR – interquartile range. | |